✦ LIBER ✦

Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs

✍ Scribed by Yee Guan Yap; A.John Camm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk and Benefit Class III Antiarrhythmi

📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Rate-dependence of antiarrhythmic and pr

✍ J. Weirich; H. Antoni 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 191 KB

Current status of class III antiarrhythm

✍ Dan M. Roden 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 699 KB

Pharmacologic and Pharmacokinetic Profil

✍ Peter R Kowey MD; Roger A Marinchak MD; Seth J Rials MD; PhD; David Bharucha MD; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 114 KB

What niche will newer class III antiarrh

✍ Bramah N. Singh; Jonnalagedda S. M. Sarma 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 606 KB

Gap junctions enhancer combined with Vau

✍ Lian-dong Li; Cun-tai Zhang; Lei Ruan; Ming-ke Ni; Xiao-qing Quan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB